Germline mutations and polymorphic variants in <i>MMR</i>, <i>E‐cadherin</i> and <i>MYH</i> genes associated with familial gastric cancer in Jiangsu of China
Yuanying Zhang(University of Science and Technology Beijing), Yaping Wang(Huashan Hospital), Xuefu Zhou, Jianhua Ding(Nanjing Medical University), Jintian Li(South China Normal University), Ming Zhu(AbbVie (United States)), Xiaomei Zhang(Peking University), Suping Li(Jiaxing University), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Ailing Xu(Jiangsu University), Xu Hu, Yimei Fan(Nanjing Medical University), Haixia Cao(Jiangsu Cancer Hospital)
Cited by 65
Related Papers
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|The Lancet Oncology|2017|327